CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE) — FDA Approval NDA217651 (BAXTER HLTHCARE CORP)
CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE) — FDA Approval NDA217651 (BAXTER HLTHCARE CORP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CYCLOPHOSPHAMIDE; Active ingredients: CYCLOPHOSPHAMIDE; Application number: NDA217651.
| Brand name | CYCLOPHOSPHAMIDE |
|---|---|
| Active ingredients | CYCLOPHOSPHAMIDE |
| Application number | NDA217651 |
| Sponsor | BAXTER HLTHCARE CORP |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20230627 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →